Loading...
Commercialized Blood-, Urinary- and Tissue-Based Biomarker Tests for Prostate Cancer Diagnosis and Prognosis
SIMPLE SUMMARY: In prostate cancer diagnosis and prognosis, clinicians often must take decisions on which prostate cancer-suspected patients should undergo biopsy and which prostate cancer-diagnosed patients should undergo treatment, to overcome overdiagnosis and overtreatment. Many biomarker-based...
Na minha lista:
| Udgivet i: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7765473/ https://ncbi.nlm.nih.gov/pubmed/33339117 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12123790 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|